Cargando…
Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer
Pancreatic cancer is one of the most lethal malignancies and is refractory to the available treatments. Pancreatic ductal adenocarcinoma (PDAC) expresses high level of inducible nitric oxide synthase (NOS2), which causes sustained production of nitric oxide (NO). We tested the hypothesis that an abe...
Autores principales: | Wang, Jian, He, Peijun, Gaida, Matthias, Yang, Shouhui, Schetter, Aaron J., Gaedcke, Jochen, Ghadimi, B. Michael, Ried, Thomas, Yfantis, Harris, Lee, Dong, Weiss, Jonathan M., Stauffer, Jimmy, Hanna, Nader, Alexander, H. Richard, Hussain, S. Perwez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288163/ https://www.ncbi.nlm.nih.gov/pubmed/27367029 http://dx.doi.org/10.18632/oncotarget.10323 |
Ejemplares similares
-
DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
por: Zhang, Geng, et al.
Publicado: (2012) -
Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease
por: Sohn, Jane J., et al.
Publicado: (2012) -
Involvement of endothelial nitric oxide synthase gene variants in the aggressiveness of uterine cervical cancer
por: Hung, Wei-Chen, et al.
Publicado: (2019) -
Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt Activation
por: Ridnour, Lisa A., et al.
Publicado: (2012) -
Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy
por: Weiss, Jonathan M., et al.
Publicado: (2010)